Sunnerstam B, Kjerstadius T, Jansson L, Giesecke J, Bergström M, Ejderhamn J
Department of Pediatrics, Central Hospital, Karlstad, Huddinge Hospital, Stockholm, Sweden.
J Clin Microbiol. 1999 Oct;37(10):3328-31. doi: 10.1128/JCM.37.10.3328-3331.1999.
A serum immunoglobulin G enzyme immunoassay (EIA) for Helicobacter pylori antibodies already in use in adults was evaluated with 99 pediatric serum samples to determine its usefulness for the study of H. pylori disease in children. The reference method used was either the (13)C-urea breath test or a biopsy culture of gastric mucosa. In children, an EIA cutoff of 0.35 absorbancy unit yielded sensitivity, specificity, and positive and negative predictive values of 93, 97, 93, and 97%, respectively. The cutoff recommended when this EIA was published for use in adults was 0.70 absorbancy unit (H. Gnarpe, P. Unge, C. Blomqvist, and S. Mäkitalo, APMIS 96:128-132, 1988). Another subset of 169 serum samples taken from children was analyzed by four serological tests in order to compare the performance of the in-house EIA with the Pyloriset, HM-CAP, and Helico-G kits. For the 169 samples, 10 (5.9%) false-positives and no false-negatives occurred with the Helico-G, 3 (1.8%) false-positives and no false-negatives occurred with the Pyloriset, and 3 (1.8%) false-positives and 1 (0.6%) false-negative occurred with the HM-CAP. For the 169 samples, 1 (0.6%) false-positive and no false-negatives occurred with the in-house EIA. Serological detection of H. pylori antibodies with our EIA seems to be valuable in diagnosing H. pylori infection in children, but only if a lowered, specific pediatric cutoff is established. The commercial kits, particularly the Helico-G, seem to overdiagnose pediatric H. pylori infection. A positive serological test for H. pylori infection, particularly for children, needs to be confirmed by a reference method because of the possibility of spontaneous eradication of infection, with a lingering serological response.
一种已用于成人的幽门螺杆菌抗体血清免疫球蛋白G酶免疫测定法(EIA),用99份儿科血清样本进行了评估,以确定其在儿童幽门螺杆菌疾病研究中的实用性。所采用的参考方法为(13)C-尿素呼气试验或胃黏膜活检培养。在儿童中,EIA临界值为0.35吸光度单位时,敏感性、特异性、阳性预测值和阴性预测值分别为93%、97%、93%和97%。该EIA发表时推荐用于成人的临界值为0.70吸光度单位(H. Gnarpe、P. Unge、C. Blomqvist和S. Mäkitalo,APMIS 96:128 - 132,1988)。从儿童中采集的另一组169份血清样本通过四种血清学检测方法进行分析,以便比较自制EIA与Pyloriset、HM - CAP和Helico - G试剂盒的性能。对于这169份样本,Helico - G出现10例假阳性(5.9%)且无假阴性,Pyloriset出现3例假阳性(1.8%)且无假阴性,HM - CAP出现3例假阳性(1.8%)和1例假阴性(0.6%)。对于这169份样本,自制EIA出现1例假阳性(0.6%)且无假阴性。用我们的EIA进行幽门螺杆菌抗体的血清学检测在诊断儿童幽门螺杆菌感染方面似乎很有价值,但前提是要设定一个较低的、特定的儿科临界值。商业试剂盒,尤其是Helico - G,似乎会过度诊断儿童幽门螺杆菌感染。由于感染可能自发根除但血清学反应仍会持续,幽门螺杆菌感染的血清学检测呈阳性,尤其是对儿童而言,需要通过参考方法进行确认。